Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.5 USD | +1.87% | +5.04% | +40.45% |
Apr. 26 | Seaport Global Starts Hims & Hers Health With Buy Rating | MT |
Apr. 16 | Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17 | MT |
Financials (USD)
Sales 2024 * | 1.19B | Sales 2025 * | 1.47B | Capitalization | 2.68B |
---|---|---|---|---|---|
Net income 2024 * | 24M | Net income 2025 * | 52M | EV / Sales 2024 * | 2.07 x |
Net cash position 2024 * | 218M | Net cash position 2025 * | 382M | EV / Sales 2025 * | 1.57 x |
P/E ratio 2024 * |
164
x | P/E ratio 2025 * |
55.8
x | Employees | 1,046 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.01% |
Latest transcript on Hims & Hers Health, Inc.
1 day | +1.87% | ||
1 week | +5.04% | ||
Current month | -19.20% | ||
1 month | -20.99% | ||
3 months | +41.72% | ||
6 months | +105.59% | ||
Current year | +40.45% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Dudum
CEO | Chief Executive Officer | 35 | 21-01-19 |
Oluyemi Okupe
DFI | Director of Finance/CFO | 57 | 22-01-23 |
Patrick Carroll
CTO | Chief Tech/Sci/R&D Officer | 66 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Delos Cosgrove
BRD | Director/Board Member | 82 | 21-01-19 |
Director/Board Member | 41 | 17-09-30 | |
Alex Bard
BRD | Director/Board Member | 49 | 21-01-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.95% | 11 M€ | -6.03% | - | |
0.02% | 237 M€ | +2.89% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 12.5 | +1.87% | 3,601,184 |
24-04-25 | 12.27 | -0.57% | 2,293,283 |
24-04-24 | 12.34 | +0.08% | 3,109,777 |
24-04-23 | 12.33 | +3.79% | 3,337,778 |
24-04-22 | 11.88 | -0.17% | 3,456,285 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.45% | 2.68B | |
+22.83% | 527M | |
+42.77% | 467M | |
-64.56% | 156M | |
-31.65% | 85.12M |
- Stock Market
- Equities
- HIMS Stock